Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of GSK's HS-20089?
HS-20089 is a monoclonal antibody conjugated commercialized by GSK, with a leading Phase I program in Solid Tumor. According to...